Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy
Indian Journal of Ophthalmology · 2023-10 · 71 (10) · 3381-3385
DOI: 10.4103/ijo.ijo_169_23 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 29.09.2023. Verfasst von K Sandeep und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Hassan Institute of Medical Sciences, Hassan, Karnataka, India. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To compare the efficacy of oral propranolol, oral rifampicin, and intravitreal anti-VEGF therapies on resolution-time and visual outcome in patients with central serous chorioretinopathy (CSCR).
Methods
A total of 30 patients with CSCR were randomized into three groups of 10 patients. Group A was given oral propranolol, Group B was given oral rifampicin 4 weeks each, and Group C was given 0.05 ml intravitreal injection of anti-VEGF. Comparisons of mean BCVA, contrast sensitivity, and central macular thickness (CMT) performed between baseline and follow-up at 4 weeks, 6 weeks, and 3 months.
Results
Statistically significant improvement in BCVA and contrast sensitivity was noted among all three groups. Complete resolution of SRF as indicated by CMT was seen at the end of 4 weeks in Group C, whereas there was a steady decline in CMT until 3 months in Groups A and B.
Conclusion
Intravitreal anti-VEGF therapy shows a significantly faster SRF resolution. However, oral propranolol and oral rifampicin could prove as a useful, cost-effective treatment of CSCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Hassan Institute of Medical Sciences, Hassan, Karnataka, India.
Zitieren
APA
Sandeep, K., Venugopal, K. C., Javagal, A. P., Acharya, P., Sreelekshmi, S. R., Narendra, N., & Nayana, P. K. (2023). Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy. Indian Journal of Ophthalmology, 71(10), 3381-3385. https://doi.org/10.4103/ijo.ijo_169_23
Vancouver
Sandeep K, Venugopal KC, Javagal AP, Acharya P, Sreelekshmi SR, Narendra N, et al. Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy. Indian Journal of Ophthalmology. 2023;71(10):3381-3385. doi:10.4103/ijo.ijo_169_23
BibTeX
@article{Sandeep2023,
author = {Sandeep, K and Venugopal, Kavitha C and Javagal, Akshatha P and Acharya, Pavana and Sreelekshmi, S R and Narendra, N and Nayana, P K},
title = {Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy},
journal = {Indian Journal of Ophthalmology},
year = {2023},
volume = {71},
number = {10},
pages = {3381--3385},
doi = {10.4103/ijo.ijo_169_23}
}
EUVIMED